FIELD: medicine.
SUBSTANCE: group of inventions relates to multilayer lipid vescible for delivery of therapeutic, prophylactic or diagnostic agent having a covalent crosslinks between lipid bilayers, wherein at least two lipid bilayers in multilayer lipid vesicle are covalently crosslinked to each other, as well as methods for production thereof, to methods of delivery of therapeutic, prophylactic or diagnostic agent and to pharmaceutical compositions containing such multilayer lipid vesicle.
EFFECT: higher efficiency of encapsulation and stability of multilayer lipid vesicles.
93 cl, 29 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MULTIDOMAIN VESICLE COMPRISING A MATERIAL WHICH CONTROLS AN IMMUNOSUPPRESSIVE FACTOR, A METHOD FOR PRODUCTION THEREOF AND AN IMMUNOMODULATING COMPOSITION THEREOF | 2018 |
|
RU2733124C1 |
| MULTIDOMAIN VESICLE COMPRISING AN IMMUNOSTIMULATING MATERIAL, A METHOD FOR PRODUCTION THEREOF AND AN IMMUNOMODULATING COMPOSITION THEREOF | 2018 |
|
RU2736639C1 |
| STABLE COMPOSITIONS OF LIPIDS AND LIPOSOMES | 2015 |
|
RU2738060C2 |
| STIMULATION OF IMMUNE RESPONSE BY ENANTIOMERS OF CATIONIC LIPIDS | 2009 |
|
RU2530555C2 |
| MODULAR PARTICLES FOR IMMUNOTHERAPY | 2014 |
|
RU2672055C2 |
| METHODS OF PRODUCING ADJUVANTED VIROSOME AND ADJUVANTED VIROSOMES, OBTAINED BY SAID METHODS | 2014 |
|
RU2694367C2 |
| TARGETING AMINOACID LIPIDS | 2013 |
|
RU2654210C2 |
| T-CELLS WITH TRANSDUCED ANTIGEN APPLIED AS ANTIGEN DELIVERY SYSTEMS | 2003 |
|
RU2330884C2 |
| DRIED RECONSTITUTED VESICLES FOR PHARMACEUTICAL APPLICATION | 2007 |
|
RU2443412C2 |
| IMPROVED LIPOSOMES AND THEIR APPLICATION | 2008 |
|
RU2482837C2 |
